MENLO
PARK, Calif., Feb. 2, 2023
/PRNewswire/ -- PacBio (NASDAQ: PACB) announced today that it will
hold its quarterly conference call to discuss its fourth quarter
and full year 2022 financial results on Thursday, February 16, 2023, at 4:30 pm Eastern Time.
The call will be webcast and may be accessed at PacBio's website
at: https://investor.pacificbiosciences.com/.
Date: Thursday, February 16, 2023
at 4:30 pm ET (1:30 pm PT)
Listen live via internet or replay:
https://investor.pacificbiosciences.com/
Toll-free: 866-652-5200
International: 412-317-6060
If using the dial-in option, please dial into the call five to
ten minutes prior to start time using the appropriate number above
and ask to join the "PacBio Q4 Earnings Call."
About PacBio
Pacific Biosciences of California, Inc. is a premier life science
technology company that is designing, developing and manufacturing
advanced sequencing solutions to help scientists and clinical
researchers resolve genetically complex problems. Our
products and technology under development stem from two highly
differentiated core technologies focused on accuracy, quality and
completeness which include our existing HiFi long read sequencing
and our emerging SBB® short read sequencing technologies. Our
products address solutions across a broad set of research
applications including human germline sequencing, plant and animal
sciences, infectious disease and microbiology, oncology, and other
emerging applications. For more information please visit
www.pacb.com and follow @PacBio.
Contacts
Investors:
Todd Friedman
650.521.8450
ir@pacb.com
Media:
Lizelda Lopez
pr@pacb.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/pacbio-to-report-fourth-quarter-and-full-year-2022-financial-results-on-february-16-2023-301737858.html
SOURCE Pacific Biosciences of California, Inc.